I like to think I know a lot about myeloma. But I always learn something new listening to @FrancescoMaura4 Excited to learn more this morning at #IEC2026. #mmsm @Myeloma_Society

1
3
37


















The EMA’s CHMP has recommended the approval of subcutaneous isatuximab via on-body injector for the treatment of multiple myeloma.
From onclive.com
Subcutaneous daratumumab was approved in Europe for patient or caregiver administration in multiple myeloma.
From onclive.com
#CureMM
From fundraise.myeloma.org